F. Rivera, M. Karthaus, J. Hecht, G. Fasola, J. Canon, R. Koukakis, J. Terwey, L. Schwartzberg (2015)
First-line treatment with modified FOLFOX6 (mFOLFOX6) + panitumumab (pmab) or bevacizumab (bev) in wild-type (WT) RAS metastatic colorectal carcinoma (mCRC): Tumor response outcomes beyond RECIST.Journal of Clinical Oncology, 33
J. Douillard, S. Siena, J. Tabernero, M. Peeters, C. Davison, S. Braun, R. Sidhu (2013)
PD-0024OVERALL SURVIVAL (OS) AND TUMOUR SHRINKAGE OUTCOMES IN PATIENTS WITH SYMPTOMATIC/ASYMPTOMATIC METASTATIC COLORECTAL CANCER (MCRC): DATA FROM THE PRIME STUDYAnnals of Oncology, 24
U. Mansmann, U. Sartorius, R. Laubender, C. Giessen, R. Esser, V. Heinemann (2013)
Deepness of response: A quantitative analysis of its impact on post-progression survival time after first-line treatment in patients with mCRC.Journal of Clinical Oncology, 31
M. Buyse, P. Thirion, R. Carlson, T. Burzykowski, G. Molenberghs, P. Piedbois (2000)
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisThe Lancet, 356
(2014)
Necker Hospital, Paris; 16 INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications
185 rue Raymond Losserand
D. Sommeijer, Q. Shi, E. Saad, E. Coart, M. Buyse, T. Burzykowski, J. Meyers, T. Maughan, R. Adams, M. Seymour, L. Saltz, R. Goldberg, Douillard Jy, Schmoll H-J., Punt Cja., C. Tournigand, B. Chibaudel, A. Gramont, D. Sargent, J. Zalcberg, Grp Arcad. (2014)
Early predictors of prolonged overall survival (OS) in patients (pts) on first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): An ARCAD study with individual patient data (IPD) on 10,962 pts.Journal of Clinical Oncology, 32
G. Deplanque, Martin Demarchi, Mohamed Hebbar, Patrick Flynn, B. Melichar, James Atkins, E. Nowara, Lemuel Moyé, D. Piquemal, D. Ritter, Patrice Dubreuil, C. Mansfield, Y. Acin, A. Moussy, Olivier Hermine, Pascal Hammel (2015)
A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancerAnnals of Oncology, 26
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumorsBreast Cancer, 12
The Meta-analysis Group in Cancer
F. Loupakis, C. Cremolini, G. Masi, S. Lonardi, V. Zagonel, L. Salvatore, E. Cortesi, G. Tomasello, M. Ronzoni, R. Spadi, A. Zaniboni, G. Tonini, A. Buonadonna, D. Amoroso, S. Chiara, C. Carlomagno, C. Boni, G. Allegrini, L. Boni, A. Falcone (2014)
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.The New England journal of medicine, 371 17
Cécile Contal, J. O'Quigley (1999)
An application of changepoint methods in studying the effect of age on survival in breast cancerComputational Statistics & Data Analysis, 30
Czech Republic; 6 Southeastern Medical Oncology Center
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.Journal of the National Cancer Institute, 92 3
S. Stintzing, D. Modest, L. Weikersthal, T. Decker, A. Kiani, U. Vehling‐Kaiser, S. Al-Batran, T. Heintges, C. Lerchenmueller, C. Kahl, G. Seipelt, F. Kullmann, W. Scheithauer, S. Held, C. Giessen, M. Moehler, A. Jagenburg, A. Jung, T. Kirchner, V. Heinemann (2014)
LBA11INDEPENDENT RADIOLOGICAL EVALUATION OF OBJECTIVE RESPONSE, EARLY TUMOR SHRINKAGE, AND DEPTH OF RESPONSE IN FIRE-3 (AIO KRK-0306) IN THE FINAL RAS EVALUABLE POPULATIONAnnals of Oncology, 25
M. Pencina, R. D'Agostino (2004)
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimationStatistics in Medicine, 23
H. Piessevaux, M. Buyse, M. Schlichting, E. Cutsem, C. Bokemeyer, S. Heeger, S. Tejpar (2013)
Use of early tumor shrinkage to predict long-term outcome in metastatic colorectal cancer treated with cetuximab.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 30
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
(1093)
Annals of Oncology original articles
G. Folprecht, A. Grothey, S. Alberts, H. Raab, C. Köhne (2005)
Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.Annals of oncology : official journal of the European Society for Medical Oncology, 16 8
Annals of Oncology – Unpaywall
Published: Jun 1, 2015
Access the full text.
Sign up today, get DeepDyve free for 14 days.